Impairment by 5-Fluorouracil of the Healing of Gastric Lesions in Rats: Effect of Lafutidine, a Histamine H2 Receptor Antagonist, Mediated by Capsaicin-Sensitive Afferent Neurons

被引:3
|
作者
Murashima, Yukiko [1 ]
Kotani, Tohru [1 ]
Hayashi, Shusaku [1 ]
Komatsu, Yoshino [1 ]
Nakagiri, Akari [1 ]
Amagase, Kikuko [1 ]
Takeuchi, Koji [1 ]
机构
[1] Kyoto Pharmaceut Univ, Dept Pharmacol & Expt Therapeut, Div Pathol Sci, Yamashina Ku, Kyoto 6078414, Japan
关键词
5-Fluorouracil; Lafutidine; Healing of HCl-induced gastric lesions; Capsaicin-sensitive afferent neurons; Rat; MUCOSAL BLOOD-FLOW; GENE-RELATED PEPTIDE; SENSORY NEURONS; NITRIC-OXIDE; ALKALINE RESPONSE; STOMACH; INJURY; CHEMOTHERAPY; PREVENTION; PROSTAGLANDINS;
D O I
10.1007/s10620-008-0325-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We investigated the influence of 5-fluorouracil (5-FU), an anti-tumor agent, on the healing of gastric lesions generated by 0.6 M HCl in rats and the effect of lafutidine, a histamine H-2 receptor antagonist, on the impaired healing. Animals fasted for 18 h were given 1 ml of 0.6 M HCl p.o., fed normally from 1 h later, and killed 1-96 h thereafter. 5-FU was given i.v. twice, 1 h and 24 h after the HCl. The gastric lesions healed spontaneously within 96 h. Although it decreased acid secretion, 5-FU markedly delayed the healing. Lafutidine, but not cimetidine, given p.o. immediately after each dosing of 5-FU significantly reversed the delay in healing by 5-FU, and this effect was attenuated by the chemical ablation of capsaicin-sensitive afferent neurons. Capsaicin also significantly reversed the delay in healing. The mucosal application of 50 mM HCl did not affect gastric mucosal blood flow (GMBF) in the normal stomach, but significantly increased it in the stomach damaged by 0.6 M HCl. The increases in GMBF were attenuated by 5-FU; however, the co-administration of lafutidine significantly restored the response. In addition, 5-FU inhibited both cell proliferation and migration in rat gastric epithelial cells (RGM1) in vitro. These results suggest that 5-FU delayed the healing of gastric lesions generated by 0.6 M HCl, probably through the inhibition of cell migration and proliferation, as well as the impairment of GMBF, and lafutidine reversed the delay in healing, mainly through the amelioration of the GMBF response mediated by capsaicin-sensitive afferent neurons.
引用
收藏
页码:36 / 45
页数:10
相关论文
共 50 条
  • [41] Effect of long-term administration of ranitidine, a histamine H2 receptor antagonist, on bone metabolism in young growing rats
    Matuszewska, Agnieszka
    Nowak, Beata
    Jedrzejuk, Diana
    Landwojtowicz, Marcin
    Sadanowicz, Ewa
    Sozanski, Tomasz
    Kwiatkowska, Joanna
    Piesniewska, Malgorzata
    Bolanowski, Marek
    Szelag, Adam
    PHARMACOLOGICAL REPORTS, 2018, 70 (05) : 951 - 954
  • [42] EFFECT OF A HISTAMINE H-2 TYPE RECEPTOR ANTAGONIST (WY-45, 727) ON THE HEALING OF GASTRIC-ULCERS IN PONIES
    MACALLISTER, CG
    SANGIAH, S
    MAUROMOUSTAKOS, A
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 1992, 6 (05) : 271 - 275
  • [43] EFFECTS OF NIZATIDINE, A NEW HISTAMINE H2-RECEPTOR ANTAGONIST, ON GASTRIC-ACID SECRETION AND VARIOUS GASTRIC AND DUODENAL LESIONS IN RATS - COMPARISON WITH CIMETIDINE
    OKABE, S
    TAKEUCHI, K
    OKADA, M
    KUMADAKI, Y
    NAKATA, M
    NAKATA, H
    FOLIA PHARMACOLOGICA JAPONICA, 1989, 93 (03) : 133 - 144
  • [44] Effect of FRG-8813, a new-type histamine H2-receptor antagonist, on the recurrence of gastric ulcer after healing by drug treatment in rats
    Ajioka, H
    Miyake, H
    Matsuura, N
    PHARMACOLOGY, 2000, 61 (02) : 83 - 90
  • [45] EFFECTS OF FRG-8813, A NEW TYPE HISTAMINE-H2-RECEPTOR ANTAGONIST, ON VARIOUS EXPERIMENTAL GASTRIC AND DUODENAL LESIONS IN RATS
    YAMAURA, T
    SHIBATA, M
    INABA, N
    ONODERA, S
    CHIDA, Y
    OHNISHI, H
    FOLIA PHARMACOLOGICA JAPONICA, 1992, 99 (06) : 401 - 410
  • [46] EFFECTS OF IGN-2098, A NEW HISTAMINE H-2-RECEPTOR ANTAGONIST, ON GASTRIC-SECRETION AND GASTRIC AND DUODENAL LESIONS INDUCED IN RATS - COMPARISON WITH ROXATIDINE
    OKABE, S
    NARITA, M
    NAKAJI, S
    TAKINAMI, Y
    KAWANO, O
    MISAKI, N
    FOLIA PHARMACOLOGICA JAPONICA, 1992, 99 (03) : 167 - 180
  • [47] EFFECTS OF A NEW HISTAMINE H-2-RECEPTOR ANTAGONIST, Z-300, ON GASTRIC-SECRETION AND GASTRODUODENAL LESIONS IN RATS - COMPARISON WITH ROXATIDINE
    OKABE, S
    TAKAGI, K
    IGATA, H
    KATO, S
    SHIMOSAKO, K
    YAMAJI, Y
    SEIKI, M
    JAPANESE JOURNAL OF PHARMACOLOGY, 1992, 59 (03): : 275 - 289
  • [48] EFFECT OF HISTAMINE AND ITS METHYL-DERIVATIVES ON CYCLIC-AMP METABOLISM IN GASTRIC-MUCOSA AND ITS BLOCKADE BY AN H2 RECEPTOR ANTAGONIST
    DOUSA, TP
    CODE, CF
    JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (01): : 334 - 337
  • [49] EFFECT OF VAGAL-STIMULATION ON GASTRIC-ACID SECRETION IN ANESTHETIZED RATS AND ITS INHIBITION BY CIMETIDINE, A HISTAMINE H-2-RECEPTOR ANTAGONIST
    GOTO, Y
    WATANABE, K
    FOLIA PHARMACOLOGICA JAPONICA, 1980, 76 (02) : P52 - P52
  • [50] EFFECTS OF FRG-8813, A NEW-TYPE HISTAMINE-H2-RECEPTOR ANTAGONIST, ON THE HEALING OF GASTRIC AND DUODENAL-ULCER IN RATS AND SPONTANEOUSLY ULCERATIVE MICE
    YAMAURA, T
    SHIBATA, M
    CHIDA, Y
    INABA, N
    ONODERA, S
    OHNISHI, H
    FOLIA PHARMACOLOGICA JAPONICA, 1992, 99 (06) : 411 - 420